Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib

The value of serum cholinesterase (ChE) level as a predictive marker in sorafenib therapy for advanced hepatocellular carcinoma (HCC) has not yet been investigated. The present retrospective study therefore analyzed the impact of the serum ChE level in 93 patients with advanced HCC treated with sora...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: TAKEDA, HARUHIKO, NISHIKAWA, HIROKI, IGUCHI, ERIKO, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, HATAMARU, KEIICHI, HENMI, SHINICHIRO, SAITO, SUMIO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, KITA, RYUICHI, KIMURA, TORU, OSAKI, YUKIO
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2013
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3956264/
https://ncbi.nlm.nih.gov/pubmed/24649154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2012.48
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak